GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genovis AB (OSTO:GENO) » Definitions » Cyclically Adjusted FCF per Share

Genovis AB (OSTO:GENO) Cyclically Adjusted FCF per Share : kr0.18 (As of Mar. 2025)


View and export this data going back to 2005. Start your Free Trial

What is Genovis AB Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Genovis AB's adjusted free cash flow per share for the three months ended in Mar. 2025 was kr0.163. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr0.18 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Genovis AB's average Cyclically Adjusted FCF Growth Rate was 500.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Genovis AB was 61.40% per year. The lowest was 34.60% per year. And the median was 41.50% per year.

As of today (2025-05-30), Genovis AB's current stock price is kr26.95. Genovis AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was kr0.18. Genovis AB's Cyclically Adjusted Price-to-FCF of today is 149.72.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Genovis AB was 1275.00. The lowest was 102.67. And the median was 313.13.


Genovis AB Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Genovis AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genovis AB Cyclically Adjusted FCF per Share Chart

Genovis AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.52 -0.30 -0.21 -0.03 0.14

Genovis AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.05 0.08 0.14 0.18

Competitive Comparison of Genovis AB's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Genovis AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genovis AB's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genovis AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Genovis AB's Cyclically Adjusted Price-to-FCF falls into.


;
;

Genovis AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genovis AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.163/132.8245*132.8245
=0.163

Current CPI (Mar. 2025) = 132.8245.

Genovis AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.187 99.995 -0.248
201509 -0.073 100.228 -0.097
201512 -0.105 100.276 -0.139
201603 -0.068 100.751 -0.090
201606 -0.219 101.019 -0.288
201609 -0.054 101.138 -0.071
201612 -0.037 102.022 -0.048
201703 -0.029 102.022 -0.038
201706 -0.062 102.752 -0.080
201709 -0.024 103.279 -0.031
201712 -0.024 103.793 -0.031
201803 -0.034 103.962 -0.043
201806 0.001 104.875 0.001
201809 0.015 105.679 0.019
201812 -0.004 105.912 -0.005
201903 0.043 105.886 0.054
201906 0.002 106.742 0.002
201909 0.104 107.214 0.129
201912 0.089 107.766 0.110
202003 -0.023 106.563 -0.029
202006 -0.002 107.498 -0.002
202009 0.004 107.635 0.005
202012 0.081 108.296 0.099
202103 0.054 108.360 0.066
202106 -0.027 108.928 -0.033
202109 0.070 110.338 0.084
202112 0.604 112.486 0.713
202203 -0.025 114.825 -0.029
202206 0.003 118.384 0.003
202209 0.077 122.296 0.084
202212 -0.069 126.365 -0.073
202303 0.708 127.042 0.740
202306 0.029 129.407 0.030
202309 0.147 130.224 0.150
202312 0.151 131.912 0.152
202403 0.276 132.205 0.277
202406 -0.005 132.716 -0.005
202409 0.011 132.304 0.011
202412 0.284 132.987 0.284
202503 0.163 132.825 0.163

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Genovis AB  (OSTO:GENO) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Genovis AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=26.95/0.18
=149.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Genovis AB was 1275.00. The lowest was 102.67. And the median was 313.13.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Genovis AB Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Genovis AB's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Genovis AB Business Description

Industry
Traded in Other Exchanges
Address
Kavlinge, Box 4, Lund, SWE, SE-24421
Genovis AB offers customers in the biopharmaceutical and research industries tools that facilitate and save time in the development of new treatment methods and diagnostics. Its enzyme products, known as SmartEnzymes, are used by scientists all over the world, and the product formats facilitate the development and quality control of biological drugs. Its products include Enzyme and Antibodies. Geographically, it operates in Sweden and Rest of the world.

Genovis AB Headlines

No Headlines